Foxo Technologies Inc. revenue by segment FOXOW

Annual Quarterly

Foxo Technologies Inc. splits its revenue 2 ways in its filings. By operating segments, the largest line in Q2 of fiscal 2026, the quarter ended Jun 30, 2026 was Health Cares at $4.5 million, 95% of the total. By sales mix, the largest line in Q2 of fiscal 2026, the quarter ended Jun 30, 2026 was Health Cares at $4.5 million, 95% of the total.

USD in millions. The percent under a figure is the change from the same quarter a year earlier.

Line	TTM Jun 30, 2026	Q2 FY2026 Jun 30, 2026	Q1 FY2026 Mar 31, 2026	Q4 FY2025 Dec 31, 2025	Q3 FY2025 Sep 30, 2025	Q2 FY2025 Jun 30, 2025	Q1 FY2025 Mar 31, 2025	Q4 FY2024 Dec 31, 2024	Q3 FY2024 Sep 30, 2024
Revenue	18	5	5	4	4	5	3	3	1
Operating segments
Health Cares	—	4 -14.2% share 94.8%	5 +51.8% share 92.9%	4 +49.6% share 94.9%	4 +195.4% share 98.9%	5 share 99.9%	3 share 99.7%	3 share 99.7%	1 share 99.3%
Life Science Services	—	0 share 5.1%	0 share 7.0%	0 share 5.0%	0 share 0.9%	—	—	—	—
Labs	—	0 -20.6% share 0.1%	0 -48.3% share 0.1%	-0 -212.8% share -0.2%	0 -5.8% share 0.2%	0 share 0.1%	0 share 0.3%	0 share 0.3%	0 share 0.7%
Sales mix
Health Cares	—	4 -14.2% share 94.8%	5 +51.8% share 92.9%	4 +49.6% share 94.9%	4 +195.4% share 98.9%	5 share 99.9%	3 share 99.7%	3 share 99.7%	1 share 99.3%
Life Science Services	—	0 share 5.1%	0 share 7.0%	0 share 5.0%	0 share 0.9%	—	—	—	—
Labs	—	0 -20.6% share 0.1%	0 -48.3% share 0.1%	-0 -212.8% share -0.2%	0 -5.8% share 0.2%	0 share 0.1%	0 share 0.3%	0 share 0.3%	0 share 0.7%

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry: Services-Commercial Physical & Biological Research (SIC 8731)
Listed as: FOXO (OTC), FOXOW (OTC)
Fiscal year ends: December 31
Incorporated in: DE
Headquarters: West Palm Beach, FL
SEC filer status: , Emerging growth company
SEC CIK: 1812360
Former names: Delwinds Insurance Acquisition Corp. (until Sep 15, 2022)

Other Services-Commercial Physical & Biological Research companies

Iqvia Holdings Inc. IQV
Incyte Corp INCY
Medpace Holdings, Inc. MEDP
Charles River Laboratories International, Inc. CRL
Icon PLC ICLR
Absci Corp ABSI
OmniAb, Inc. OABI
NRC Health NRC

All 17 Services-Commercial Physical & Biological Research companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.